Abstract
Human embryos carrying natural mutations causative of diseases are typically discarded following preimplantation genetic diagnosis (PGD). However, PGD-tested and affected embryos may be used for derivation of disease-specific human embryonic stem cells (hESC) that may represent powerful in vitro models to study disease development, progression, and screen potential therapeutics. Aims were to produce genetically normal and hypertrophic cardiomyopathy (HCM) disease-specific hESC lines, direct their differentiation to cardiomyocytes, and determine if the disease-specific hESC line phenocopied HCM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have